日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Pediatric and adult H3 K27M-mutant diffuse midline glioma treated with the selective DRD2 antagonist ONC201

使用选择性 DRD2 拮抗剂 ONC201 治疗儿童和成人 H3 K27M 突变型弥漫性中线胶质瘤

Chi, Andrew S; Tarapore, Rohinton S; Hall, Matthew D; Shonka, Nicole; Gardner, Sharon; Umemura, Yoshie; Sumrall, Ashley; Khatib, Ziad; Mueller, Sabine; Kline, Cassie; Zaky, Wafik; Khatua, Soumen; Weathers, Shiao-Pei; Odia, Yazmin; Niazi, Toba N; Daghistani, Doured; Cherrick, Irene; Korones, David; Karajannis, Matthias A; Kong, Xiao-Tang; Minturn, Jane; Waanders, Angela; Arillaga-Romany, Isabel; Batchelor, Tracy; Wen, Patrick Y; Merdinger, Krystal; Schalop, Lee; Stogniew, Martin; Allen, Joshua E; Oster, Wolfgang; Mehta, Minesh P

Hyaluronan synthase 3 variant and anthracycline-related cardiomyopathy: a report from the children's oncology group

透明质酸合成酶3变体与蒽环类药物相关性心肌病:儿童肿瘤协作组的一份报告

Wang, Xuexia; Liu, Wei; Sun, Can-Lan; Armenian, Saro H; Hakonarson, Hakon; Hageman, Lindsey; Ding, Yan; Landier, Wendy; Blanco, Javier G; Chen, Lu; Quiñones, Adolfo; Ferguson, Daniel; Winick, Naomi; Ginsberg, Jill P; Keller, Frank; Neglia, Joseph P; Desai, Sunil; Sklar, Charles A; Castellino, Sharon M; Cherrick, Irene; Dreyer, ZoAnn E; Hudson, Melissa M; Robison, Leslie L; Yasui, Yutaka; Relling, Mary V; Bhatia, Smita